Phillip B. Donenberg - Net Worth and Insider Trading
Phillip B. Donenberg Net Worth
The estimated net worth of Phillip B. Donenberg is at least $269,480 dollars as of 2024-05-12. Phillip B. Donenberg is the Director of Taysha Gene Therapies Inc and owns about 114,111 shares of Taysha Gene Therapies Inc (TSHA) stock worth over $267,020. Phillip B. Donenberg is also the Director of Avrobio Inc and owns about 2,000 shares of Avrobio Inc (AVRO) stock worth over $2,460. Details can be seen in Phillip B. Donenberg's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Phillip B. Donenberg has not made any transactions after 2023-08-16 and currently still holds the listed stock(s).
Transaction Summary of Phillip B. Donenberg
Phillip B. Donenberg Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Phillip B. Donenberg owns 5 companies in total, including Taysha Gene Therapies Inc (TSHA) , Avrobio Inc (AVRO) , and AveXis Inc (AVXS) among others .
Click here to see the complete history of Phillip B. Donenberg’s form 4 insider trades.
Insider Ownership Summary of Phillip B. Donenberg
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TSHA | Taysha Gene Therapies Inc | 2023-08-16 | director |
| AVRO | Avrobio Inc | 2021-02-17 | director |
| AVXS | AveXis Inc | 2018-05-15 | Chief Financial Officer |
 | | 2014-07-24 | director |
| | 2003-08-04 | CFO & Treasurer and Secretary |
Phillip B. Donenberg Latest Holdings Summary
Phillip B. Donenberg currently owns a total of 2 stocks. Among these stocks, Phillip B. Donenberg owns 114,111 shares of Taysha Gene Therapies Inc (TSHA) as of August 16, 2023, with a value of $267,020 and a weighting of 99.09%. Phillip B. Donenberg also owns 2,000 shares of Avrobio Inc (AVRO) as of February 17, 2021, with a value of $2,460 and a weighting of 0.91%.
Latest Holdings of Phillip B. Donenberg
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TSHA | Taysha Gene Therapies Inc | 2023-08-16 | 114,111 | 2.34 | 267,020 |
| AVRO | Avrobio Inc | 2021-02-17 | 2,000 | 1.23 | 2,460 |
Holding Weightings of Phillip B. Donenberg
Phillip B. Donenberg Form 4 Trading Tracker
According to the SEC Form 4 filings, Phillip B. Donenberg has made a total of 2 transactions in Taysha Gene Therapies Inc (TSHA) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Taysha Gene Therapies Inc is the acquisition of 111,111 shares on August 16, 2023, which cost Phillip B. Donenberg around $100,000.
According to the SEC Form 4 filings, Phillip B. Donenberg has made a total of 1 transactions in Avrobio Inc (AVRO) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Avrobio Inc is the acquisition of 2,000 shares on February 17, 2021, which cost Phillip B. Donenberg around $23,420.
Insider Trading History of Phillip B. Donenberg
- 1
Phillip B. Donenberg Trading Performance
GuruFocus tracks the stock performance after each of Phillip B. Donenberg's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Phillip B. Donenberg is -29.52%. GuruFocus also compares Phillip B. Donenberg's trading performance to market benchmark return within the same time period. The performance of stocks bought by Phillip B. Donenberg within 3 months outperforms 0 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Phillip B. Donenberg's insider trading performs compared to the benchmark.
Performance of Phillip B. Donenberg
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 23.33 | | | | | |
| Relative Return to S&P 500(%) | 24.09 | | | | | |
Phillip B. Donenberg Ownership Network
Phillip B. Donenberg Owned Company Details
What does Taysha Gene Therapies Inc do?
Who are the key executives at Taysha Gene Therapies Inc?
Phillip B. Donenberg is the director of Taysha Gene Therapies Inc. Other key executives at Taysha Gene Therapies Inc include director & 10 percent owner Paul B Manning , Chief Financial Officer Kamran Alam , and 10 percent owner Session R.a. Ii .
Taysha Gene Therapies Inc (TSHA) Insider Trades Summary
Over the past 18 months, Phillip B. Donenberg made 1 insider transaction in Taysha Gene Therapies Inc (TSHA) with a net purchase of 111,111. Other recent insider transactions involving Taysha Gene Therapies Inc (TSHA) include a net sale of 549,095 shares made by Session R.a. Ii , a net purchase of 16,566,667 shares made by Paul B Manning , and a net purchase of 777,778 shares made by Stalfort John A Iii .
In summary, during the past 3 months, insiders sold 0 shares of Taysha Gene Therapies Inc (TSHA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 582,095 shares of Taysha Gene Therapies Inc (TSHA) were sold and 17,905,000 shares were bought by its insiders, resulting in a net purchase of 17,322,905 shares.
Taysha Gene Therapies Inc (TSHA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Taysha Gene Therapies Inc Insider Transactions
Phillip B. Donenberg Mailing Address
Above is the net worth, insider trading, and ownership report for Phillip B. Donenberg. You might contact Phillip B. Donenberg via mailing address: C/o Avexis, Inc., 2275 Half Day Road, Suite 200, Bannockburn Il 60015.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
